• Home
  • Bharat Biotech

Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old

SII, Bharat Biotech cut COVID vaccine prices for private hospitals to Rs 225

No impact of WHO action on Covaxin, have not supplied to any UN agency: Bharat Biotech

Bharat Biotech says Covaxin safe for booster dose against Covid

India-made Covaxin now on UK’s approved travel list

Covaxin 77.8% effective against COVID-19: Lancet study

Ideal time for booster dose for COVID vaccine is 6 months after 2nd dose: Bharat Biotech MD

‘Additional clarifications’ needed from Bharat Biotech to conduct final assessment of Covaxin: WHO

Decision on Bharat Biotech’s Covaxin EUL in October: WHO

Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials

Bharat Biotech awaits feedback from WHO for Covaxin EUL

Bharat Biotech awaits feedback from WHO for Covaxin EUL

Guj: First commercial batch of Covaxin released from Bharat Biotech’s new plant

Govt panel recommends EUA to Zydus Cadila’s 3-dose COVID-19 vaccine

Bharat Biotech’s Covaxin effective against Delta Plus variant of COVID-19:Study

Bharat Biotech terminates MoU with Brazilian partners after graft allegations

Bharat Biotech commits to supply 500 Mn doses of Covaxin to Centre for immunisation programme

Decision on emergency use listing of Covaxin likely in 4-6 weeks, says WHO

Brazil suspends Bharat Biotech’s Covaxin order over graft allegations

Bharat Biotech’s pre-submission meeting for Covaxin EUL with WHO on June 23

What is the role of animal serum in making of vaccines?

Social media posts twisted facts, final product doesn’t have newborn calf serum: Centre on Covaxin

Rs 150 per Covaxin dose to Centre not sustainable in long run: Bharat Biotech

Will students administered with Covaxin be allowed to travel abroad?

Bharat Biotech’s US partner Ocugen submits ‘Master File’ to FDA on Covaxin

WHO says ‘more information’ required from Bharat Biotech for emergency use listing of Covaxin

Paediatric trials of Covaxin may begin in June: Bharat Biotech official

‘Bharat Biotech’s K’taka facility will have capacity to make 4-5 cr doses of Covaxin a month by August-end’

DCGI approves Phase 2, 3 clinical trials of Bharat Biotech’s Covaxin for 2 -18 year-olds

50 employees of Bharat Biotech test COVID-19 positive; Joint MD’s tweet draws bouquets and brickbats

Bharat Biotech says can’t provide additional Covaxin doses to Delhi: Sisodia

18 states getting direct supply of Covaxin since May 1, says Bharat Biotech

Fact Check: Did government approve Bharat Biotech’s Covaxin for children above 12 years?

Bharat Biotech seeks DCGI’s nod to extend shelf life of Covaxin

Latest Additions

Hijab not allowed for KCET exams

Front suspension of Ola Electric scooter broke while riding, claims user

SC sets aside HC order staying SFIO probe into 9 companies related to Sahara group

On a roll, RCB fancy their chances against Royals in Qualifier 2

Even vaccinated people can develop Long COVID, study finds

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.